TB-500 (Thymosin Beta-4)

TB-500 is a synthetic 43–amino-acid peptide fragment derived from the naturally occurring protein Thymosin Beta-4. It has been investigated in preclinical models for its potential role in cellular processes related to wound-healing, inflammation pathways, and angiogenesis. In rodent injury and in vitro assays, TB-500 has been reported to influence fibroblast migration, cytokine modulation, and vascular signaling.

Each vial contains 10 mg of TB-500, manufactured in the USA, HPLC-verified to ≥ 99% purity, endotoxin-screened (< 0.1 EU/mg), and supplied in lyophilized form for laboratory research.